Sri Lanka, Myanmar, and several other countries are also trying to procure the vaccine developed by Globe Biotech Ltd, says the firm’s chairman
A private company of Nepal has signed a deal with Globe Biotech Ltd of Bangladesh with the intention of buying 2 million doses of its Covid-19 vaccine.
Globe Biotech Ltd Chairman Harunur Rashid disclosed the information at a press briefing on Thursday, in the presence of Nepal Ambassador to Bangladesh Dr Banshidhar Mishra.
Anmol Healthcare is the company that signed the agreement, mentioned Rashid while responding to a query.
Besides Nepal, Sri Lanka, Myanmar, and several other countries are also trying to procure the vaccine developed by Globe Biotech Ltd, said the firm’s chairman.
“We received an order for 20 million vaccines from another country but we cannot reveal its name right now due to privacy concerns,” said the Globe Biotech chairman.
Also Read- Globe Biotech’s three vaccines on WHO list
During the press briefing, Rashid also said he is hopeful that America and some European countries might purchase Globe Biotech’s Covid-19 vaccine, BANCOVID.
After visiting the factory of Globe Biotech, Nepali Ambassador to Bangladesh Dr Mishra said: “The people of Nepal and even the Nepali government are very excited and pleased that our closest neighbour is developing the vaccine.”
Nepal will definitely purchase vaccines from Bangladesh for its people, he added.
“We are also interested to run a trial for this vaccine in Nepal if we get the clearance from Bangladesh’s side,” the envoy said.
He continued: “Globe Biotech Ltd is preparing to apply to the Bangladesh Medical Research Council (BMRC) for conducting the first phase of the vaccine trial.
“Several Nepali companies are in talks with Globe Biotech for the vaccine; I have received a letter from one of the companies in this regard.
“Perhaps the government of Nepal will directly sign deals at a later date.”
In July, Globe Biotech claimed to be the first Bangladeshi company to develop a Covid-19 vaccine.
Dr Asif Mahmud, assistant manager and in-charge, Research and Development, Globe Biotech Ltd, said the company achieved success in preliminary animal modelling trials for their Covid-19 vaccine.
He said they went for the SPR method for the tests. SPR or surface plasmon resonance is an optical technique utilized for detecting molecular interactions.
Globe Biotech Ltd on October 5 said they wanted to bring the vaccine to the market by January next year if they are allowed to launch the first phase of human trials soon, reports UNB.
The Bangladeshi pharmaceutical company said they have completed all the necessary preparations for making their vaccine initiative a success, but they said everything now depends on the government’s cooperation in completing the required process.